Rheumatology

Featured Article

Exploring the Clinical Implications of Cannabinoid Use in Rheumatoid Arthritis

Exploring the Clinical Implications of Cannabinoid Use in Rheumatoid Arthritis

Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.

Latest

Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation

Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation

Pain catastrophizing decreases over time in patients with RA who respond to DMARD treatment.

DAS28 Patient-Reported Components Identify Fibromyalgia in Rheumatoid Arthritis

DAS28 Patient-Reported Components Identify Fibromyalgia in Rheumatoid Arthritis

The assessment of patient-reported components of the DAS28 can be a useful way to identify patients with fibromyalgic RA.

Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA

Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA

Widespread nonarthritic pain is linked to worse patient-reported and composite psoriatic arthritis activity measures.

Multiple Factors to Consider When Selecting NSAID for Arthritis

Multiple Factors to Consider When Selecting NSAID for Arthritis

Factors to be considered when choosing the correct nonsteroidal anti-inflammatory drug (NSAID) for arthritis include effectiveness, concurrent health conditions, and frequency of use.

Increased Rates of Opioid- and Injection Drug Use-Related Septic Knee Arthritis

Increased Rates of Opioid- and Injection Drug Use-Related Septic Knee Arthritis

The percentage of patients with septic arthritis related to opioid or injection drug use was found to have increased from 2000 to 2013.

Efficacy, Safety of OnabotulinumtoxinA Assessed for Knee OA Treatment

Efficacy, Safety of OnabotulinumtoxinA Assessed for Knee OA Treatment

Investigators sought to evaluate intra-articular onabotulinumtoxinA 400 U and 200 U in reducing symptoms of knee OA in patients with nociceptive pain.

Consensi Approved to Treat Hypertension and Osteoarthritis Pain

Consensi Approved to Treat Hypertension and Osteoarthritis Pain

Consensi combines amlodipine besylate, a calcium-channel blocker (CCB), and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID).

Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression

Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression

The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.

Illness Perceptions Mediate Back Pain, Quality of Life in Early Axial Spondyloarthritis

Illness Perceptions Mediate Back Pain, Quality of Life in Early Axial Spondyloarthritis

Illness perceptions are important in the relationship between back pain and health-related quality of life in patients suspected of axial spondyloarthritis.

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.